Navigation Links
Frost & Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market
Date:11/16/2009

LONDON, Nov. 16 /PRNewswire/ -- The "omics" revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years. New biomarkers are discovered each day and this rapid development promises excellent growth potential for the biomarker analysis market. However, due to various challenges faced in biomarker validation and assay development, there is a huge lag between the time that a biomarker is discovered in the laboratory and the time it is actually commercialized.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

In an upcoming Analyst Briefing, Frost & Sullivan will therefore focus on the potential of the European Biomarker Analysis Market. The briefing will be held on Tuesday, 24th November 2009, at 3 p.m. GMT. Highlights of the briefing include an analysis of current trends, challenges, drivers and restraints, significant market developments, a survey of market opportunities and what lies ahead in this vibrant field.

"All stakeholders in the biomarker industry need to come together to circumvent the bottlenecks in this field," says Frost & Sullivan Senior Research Analyst Rasika Ramachandran. "Although the task of bringing together the entire industry for this cause is a formidable one, it seems to be the only solution to the challenge of making biomarker testing reach every drug discovery lab. The long term benefits of such an undertaking should aid in justifying the efforts that are involved in making it happen."

The discussion on the European Biomarker Analysis market will be beneficial to biomarker companies, pharmaceutical manufacturers, biotechnology companies, drug discovery firms and contract research organizations.

To participate in this webinar, please email Patrick Cairns at patrick.cairns@frost.com with the following
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Frost & Sullivan Recognizes Agile Therapeutics for Its Innovative Weekly Low-Dose Contraceptive Patch
2. Frost & Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers
3. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
4. Emergence of Newer Drug Classes to Treat Diabetes and Co-morbidities Key to Market Expansion, Reveals Frost & Sullivan
5. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
6. Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan
7. Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities
8. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
9. Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan
10. Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation
11. Frost & Sullivan: Lower Import Duties and Rising Customer Demand to Boost Russian Electronics Manufacturing Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... 22, 2014 ITRA Global, one of ... of commercial real estate, has further expanded its global ... Perth and Brisbane, Western Australia, reports Mylinda Vick, CCIM, ... ITRA Global / ACORPP (Australian Corporate Property and ... company providing property services to a wide range of ...
(Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one of the ... Maroulis, Pharm.D. to the newly created position of Vice ... position, Dr. Maroulis will continue to manage the entire ... multi-site pharmacies as the company expands. Dr. Maroulis has ... he has served in many different capacities in the ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... fight cancer, rheumatoid arthritis, as well as enhance ... CEL-SCI Corporation (NYSE Amex: CVM ) ... 11th annual National Foundation of Infectious Diseases Conference ... L.E.A.P.S.(TM) (Ligand Epitope Antigen Presentation System) vaccine technology ...
... April 27 MannKind Corporation (Nasdaq: MNKD ... on Monday, May 4, 2009.Management of the Company will ... financial results and other Company developments at 4:00 PM ... will be its Chairman and Chief Executive Officer, Alfred ...
... SAN DIEGO, April 27 Cadence Pharmaceuticals, Inc. (Nasdaq: ... clinical trials of its investigational product candidate, Acetavance(TM) (intravenous ... Regional Anesthesia and Pain Medicine (ASRA) 34th Annual Regional ... and at the Society of Hospital Medicine (SHM) Annual ...
Cached Biology Technology:CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease 2CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease 3CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease 4MannKind Corporation to Hold First Quarter Financial Results Conference Call on May 4, 2009 2Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences 2
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/11/2014)... 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition ... report to their offering. ... the adoption of multimodal biometric systems. Multimodal biometric ... individual for verification and identification purposes. This helps ...
(Date:12/10/2014)... , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ... accuracy is the ultimate driver in long-term mass consumer ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... category for the largest human-designed protein, then a team of ... have designed and successfully synthesized a variant of a protein ... It is more than twice the size of the previous ... of Washington in 2003. The synthetic protein, designated FLR, ...
... A study conducted by researchers at the Johns Hopkins ... patterns of drug resistance in malaria-causing parasites taken from ... in human blood samples showed a high prevalence for ... widely used to treat malaria in the region. However, ...
... CHAPEL HILL, N.C. After a heart attack, the portions ... scar tissue. Researchers have long sought ways to avoid this ... its ability to pump blood throughout the body and eventually ... of North Carolina at Chapel Hill School of Medicine shows ...
Cached Biology News:Creation of the largest human-designed protein boosts protein engineering efforts 2Creation of the largest human-designed protein boosts protein engineering efforts 3Contrasting patterns of malaria drug resistance found between humans and mosquitoes 2Scarring a necessary evil to prevent further damage after heart attack 2
... DNA Polymerase is a premium quality recombinant ... thermostable enzyme is suitable for a wide ... highest purity and reproducible performance, each preparation ... quality control assays. NovaTaq DNA Polymerase possesses ...
... cell sorter sets a new standard for ... a revolutionary new design in instrumentation, this ... multicolor analysis. The BD FACSAria instrument is ... fixed-alignment cuvette flow cell. This new ...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Biology Products: